Edesa Biotech, Inc. business relationships
Companies named in Edesa Biotech, Inc.’s 10-K filed 2025-12-12, and public companies whose annual reports name Edesa Biotech, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 4 / 100 Top 3% in its category
- Agent readiness
- 0 / 100
- AI adoption
- 0 / 100
Named in Edesa Biotech, Inc.’s annual report 2
“The BARDA-funded study is being managed under a BARDA contract with PPD Development, LP, a clinical research business of Thermo Fisher Scientific, Inc. For the EB05 cohort of the study, patients are being randomized one-to-one to either EB05 + SOC or to a placebo + SOC control arm.” SEC filing
“In August 2017, Edesa Biotech Research entered into an exclusive license and development agreement with Pendopharm, a division of Pharmascience Inc. (the "Pendopharm License Agreement").” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.